These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21451107)

  • 21. Do T cells need endogenous peptides for activation?
    Gascoigne NR
    Nat Rev Immunol; 2008 Nov; 8(11):895-900. PubMed ID: 18846098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-receptors and recognition of self at the immunological synapse.
    Gascoigne NR; Zal T; Yachi PP; Hoerter JA
    Curr Top Microbiol Immunol; 2010; 340():171-89. PubMed ID: 19960314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells.
    Margalit A; Fishman S; Berko D; Engberg J; Gross G
    Int Immunol; 2003 Nov; 15(11):1379-87. PubMed ID: 14565936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell Receptors Engineered
    Sharma P; Harris DT; Stone JD; Kranz DM
    Cancer Immunol Res; 2019 Dec; 7(12):2025-2035. PubMed ID: 31548259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.
    Stone JD; Chervin AS; Kranz DM
    Immunology; 2009 Feb; 126(2):165-76. PubMed ID: 19125887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different strategies adopted by K(b) and L(d) to generate T cell specificity directed against their respective bound peptides.
    Bowerman NA; Colf LA; Garcia KC; Kranz DM
    J Biol Chem; 2009 Nov; 284(47):32551-61. PubMed ID: 19755422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.
    Purbhoo MA; Boulter JM; Price DA; Vuidepot AL; Hourigan CS; Dunbar PR; Olson K; Dawson SJ; Phillips RE; Jakobsen BK; Bell JI; Sewell AK
    J Biol Chem; 2001 Aug; 276(35):32786-92. PubMed ID: 11438524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Competition for self-peptide-MHC complexes and cytokines between naive and memory CD8+ T cells expressing the same or different T cell receptors.
    Ge Q; Bai A; Jones B; Eisen HN; Chen J
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3041-6. PubMed ID: 14976256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutting edge: inhibitory effects of CD4 and CD8 on T cell activation induced by high-affinity noncognate ligands.
    Chervin AS; Stone JD; Bowerman NA; Kranz DM
    J Immunol; 2009 Dec; 183(12):7639-43. PubMed ID: 19923452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules.
    Ge Q; Stone JD; Thompson MT; Cochran JR; Rushe M; Eisen HN; Chen J; Stern LJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13729-34. PubMed ID: 12374859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous altered peptide ligands can affect peripheral T cell responses.
    Vidal K; Hsu BL; Williams CB; Allen PM
    J Exp Med; 1996 Apr; 183(4):1311-21. PubMed ID: 8666889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1
    Doorduijn EM; Sluijter M; Querido BJ; Seidel UJE; Oliveira CC; van der Burg SH; van Hall T
    Front Immunol; 2018; 9():60. PubMed ID: 29422902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirement for CD8-major histocompatibility complex class I interaction in positive and negative selection of developing T cells.
    Killeen N; Moriarty A; Teh HS; Littman DR
    J Exp Med; 1992 Jul; 176(1):89-97. PubMed ID: 1613468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling.
    Zhao X; Sankaran S; Yap J; Too CT; Ho ZZ; Dolton G; Legut M; Ren EC; Sewell AK; Bertoletti A; MacAry PA; Brzostek J; Gascoigne NRJ
    Nat Commun; 2018 Jul; 9(1):2716. PubMed ID: 30006605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Coreceptor function of CD4 in response to MHC class I molecule].
    Zvezdova ES; Grinenko TS; Pobezinskaia EL; Pobezinskiĭ LA; Kazanskiĭ DB
    Mol Biol (Mosk); 2008; 42(4):662-72. PubMed ID: 18856067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of TCRs with MHC-peptide complexes: a quantitative basis for mechanistic models.
    Margulies DH
    Curr Opin Immunol; 1997 Jun; 9(3):390-5. PubMed ID: 9203420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T Cell Receptor Engineering and Analysis Using the Yeast Display Platform.
    Smith SN; Harris DT; Kranz DM
    Methods Mol Biol; 2015; 1319():95-141. PubMed ID: 26060072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precommitment of CD4+CD8+ thymocytes to either CD4 or CD8 lineages.
    Crompton T; Lees RK; Pircher H; MacDonald HR
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8982-6. PubMed ID: 8415641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late postnatal expansion of self-reactive CD8alphaalpha+ intestinal intraepithelial lymphocytes in mice.
    Podd BS; Aberg C; Christopher TL; Perez-Cano F; Camerini V
    Autoimmunity; 2004 Dec; 37(8):537-47. PubMed ID: 15763916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.